GPS Wealth Strategies Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47
| Closed | -$3.09K | – | 1523 |
|
|
2024
Q4 | $3.09K | Buy |
+47
| New | +$3.09K | ﹤0.01% | 1175 |
|
|
2023
Q3 | – | Sell |
-6
| Closed | -$520 | – | 1285 |
|
|
2023
Q2 | $520 | Hold |
6
| – | – | ﹤0.01% | 1192 |
|
|
2023
Q1 | $583 | Buy |
+6
| New | +$583 | ﹤0.01% | 1191 |
|
|
2022
Q4 | – | Sell |
-6
| Closed | -$1K | – | 226 |
|
|
2022
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1066 |
|
|
2022
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1108 |
|
|
2022
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1044 |
|
|
2021
Q4 | $1K | Sell |
6
-12
| -67% | -$2K | ﹤0.01% | 1008 |
|
|
2021
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 976 |
|
|
2021
Q2 | $2K | Hold |
18
| – | – | ﹤0.01% | 952 |
|
|
2021
Q1 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 895 |
|